New Research Links Shared Origins of Pineoblastoma to Multiple Brain Tumor Dependencies Recent findings uncover a common molecular dependency in various brain tumors linked to pineoblastoma, suggesting transformative therapeutic targets.

New Research Links Shared Origins of Pineoblastoma to Multiple Brain Tumor Dependencies #USA #Memphis #brain_tumors #Pineoblastoma #St._Jude_Research

Monteris Medical’s NeuroBlate® System Offers New Hope for Brain Tumor Patients through Enhanced Immunotherapy Monteris Medical's NeuroBlate® System has shown promising results in improving immunotherapy effectiveness for recurrent high-grade brain tumors, exceeding expectations for patient survival.

Monteris Medical’s NeuroBlate® System Offers New Hope for Brain Tumor Patients through Enhanced Immunotherapy #United_States #Immunotherapy #Minnetonka #brain_tumors #NeuroBlate

Children's Brain Tumor Network Launches New Brand to Enhance Global Pediatric Research Impact The Children's Brain Tumor Network has unveiled its updated branding, highlighting its leadership in pediatric brain tumor research and data-driven initiatives.

Children's Brain Tumor Network Launches New Brand to Enhance Global Pediatric Research Impact #United_States #Philadelphia #Pediatric_Research #brain_tumors #Children’s_Brain_Tumor_Network

GT Medical Technologies to Showcase Innovations at J.P. Morgan Healthcare Conference GT Medical Technologies, an innovative medical device company, will highlight breakthroughs in brain tumor treatment at the upcoming J.P. Morgan Healthcare Conference.

GT Medical Technologies to Showcase Innovations at J.P. Morgan Healthcare Conference #United_States #San_Francisco #GammaTile #GT_Medical #brain_tumors

GT Medical Technologies Celebrates Baylor St. Luke's as New Center of Excellence for GammaTile Treatment GT Medical Technologies honors Baylor St. Luke's Medical Center, recognizing its expertise in the innovative GammaTile procedure, enhancing brain tumor care.

GT Medical Technologies Celebrates Baylor St. Luke's as New Center of Excellence for GammaTile Treatment #United_States #GammaTile #brain_tumors #Tempe,_Arizona #GT_Medical_Technologies

Innovative GammaTile Treatment Shows Promising Results in Brain Tumor Control during Clinical Trials Recent clinical trial results reveal GammaTile's effectiveness in enhancing tumor control for operable brain metastases, leading to better patient outcomes compared to standard treatments.

Innovative GammaTile Treatment Shows Promising Results in Brain Tumor Control during Clinical Trials #United_States #Tempe #GammaTile #GT_Medical #brain_tumors

SonoClear AS Achieves FDA Breakthrough Designation for Innovative SonoClear® System SonoClear AS has received FDA breakthrough designation for its SonoClear® System, enhancing imaging during brain tumor surgery. This breakthrough aims to improve surgical outcomes.

SonoClear AS Achieves FDA Breakthrough Designation for Innovative SonoClear® System #Norway #Oslo #brain_tumors #FDA_Breakthrough #SonoClear

GT Medical Technologies Announces New Center of Excellence for GammaTile® Treatment Program GT Medical Technologies has designated Goodman Campbell Brain and Spine as a GammaTile® Center of Excellence, enhancing treatment options for brain tumors.

GT Medical Technologies Announces New Center of Excellence for GammaTile® Treatment Program #United_States #Tempe #brain_tumors #GT_Medical_Technologies #GammaTile®

Introducing the Innovative PDT Sheet II for Malignant Brain Tumor Treatment Kono Seisakusho announces the launch of the PDT Sheet II on July 1, 2025, aimed at preventing recurrence in malignant brain tumor treatments using PDT.

Introducing the Innovative PDT Sheet II for Malignant Brain Tumor Treatment #Japan #brain_tumors #Kono_Seisakusho #Ichikawa #PDT_Sheet_II

Legal-Bay Pre-Settlement Funding Focuses on New Lawsuits Linked to Depo-Provera Birth Control Legal-Bay is closely monitoring lawsuits involving Depo-Provera, as claims rise about severe side effects including brain tumors. Victims can seek financial support.

Legal-Bay Pre-Settlement Funding Focuses on New Lawsuits Linked to Depo-Provera Birth Control #United_States #Jersey_City #lawsuit_funding #Depo-Provera #brain_tumors

⚡My new image🥼🔍 🌈
#Gliomas are deadly brain tumors that suppress the #immune_system, making them hard to treat. Authors uncovered four immune programs: two unique to #brain_tumors + two shared with other #cancers. These patterns aren’t based on cell type but are driven by the #tumor_environment!

GT Medical Technologies Secures $37 Million to Propel GammaTile® Expansion for Brain Tumor Patients in the U.S. GT Medical Technologies has secured $37 million in a Series D financing round, aimed at advancing the GammaTile® treatment for brain tumors.

GT Medical Technologies Secures $37 Million to Propel GammaTile® Expansion for Brain Tumor Patients in the U.S. #United_States #Tempe #GammaTile #GT_Medical #brain_tumors